Update your browser

Your browser (Internet Explorer) is out of date.

Update your browser for more security, comfort and the best experience on this site.

Selexis, Inc.

Selexis is the only company that enables biopharmaceutical companies to produce ANY recombinant therapeutic protein, because we have the ability to understand and modify our cells to address productivity and expression challenges.

55 New Montgomery St., Suite 605, San Francisco, CA 94105, United States

Profile Navigation
This is a community generated profile. If you would like to claim it, please contact us.

About

Our Company

Selexis is the only company that enables biopharmaceutical companies to produce ANY recombinant therapeutic protein, because we have the ability to understand and modify our cells to address productivity and expression challenges. We have developed proprietary protein expression tools that can be used with predictability and a high commitment to safety.

Selexis SA is a scientific pioneer and global leader in mammalian (suspension-adapted CHO-K1) cell line generation that has been setting the pace of innovation in protein expression and establishing new benchmarks in bioproduction for more than a decade.

Markets

areas of proficiency

Company Type

Choose Company Type

Cancel

Company Size

< 10

Choose Company Size

Cancel

Contact Info

get in touch

  • Location:

    Other: 55 New Montgomery St., Suite 605, San Francisco, CA 94105, United States